Evidence map›Paper›PMID 34064541›Full record

ArticleNutrients2021

Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.

Rakel Nurmi, Ilma Korponay-Szabó, Kaija Laurila, Heini Huhtala, Onni Niemelä, Jukka Mustonen, Satu Mäkelä, Katri Kaukinen, Katri Lindfors

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Rakel NurmiCeliac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.ORCID 0000-0002-6870-558X
Ilma Korponay-SzabóCeliac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.ORCID 0000-0003-0554-2629
Kaija LaurilaCeliac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Heini HuhtalaFaculty of Social Sciences, Tampere University, 33520 Tampere, Finland.
Onni NiemeläMedical Research Unit, Seinäjoki Central Hospital, 60220 Seinäjoki, Finland.
Jukka MustonenFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Satu MäkeläFaculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.ORCID 0000-0001-6967-2401
Katri KaukinenCeliac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Katri LindforsCeliac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.ORCID 0000-0001-7417-5151
Tampere University · FIUniversity of Debrecen · HU

Funding

Tampere University Doctoral Schoolthe Academy of Finlandthe Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospitalthe European Union and the Hungarian State Interreg Danube DTP571 CD SKILLSthe European Union and the Hungarian State the GINOP-2.3.2-15-2016-00015the Finnish Celiac Societythe Finnish Kidney and Liver Associationthe Hungarian National Research, Development and Innovation Fund NKFI 120392the Sigrid Jusélius Foundation
6 · The paper itself

Abstract

An association between celiac disease and IgA nephropathy (IgAN) has been suggested. In celiac disease, in addition to circulating in serum, IgA-class tissue transglutaminase (tTG) autoantibodies are deposited in the small bowel mucosa and extraintestinal organs. In this case series of IgAN patients with or without celiac disease, we studied whether celiac disease-type IgA-tTG deposits occur in kidney biopsies. The study included nine IgAN patients, four of them with celiac disease. At the time of the diagnostic kidney biopsy serum tTG autoantibodies were measured and colocalization of IgA and tTG was investigated in the frozen kidney biopsies. Three IgAN patients with celiac disease had IgA-tTG deposits in the kidney even though in two of these the celiac disease diagnosis had been set years later. These deposits were not found in a patient with already diagnosed celiac disease following a gluten-free diet. Of the five non-celiac IgAN patients, three had IgA-tTG deposits in the kidney. We conclude that tTG-targeted IgA deposits can be found in the kidney biopsies of gluten-consuming IgAN patients but their specificity to celiac disease seems limited.

Indexed as

BiopsyAdultAutoantibodiesCeliac DiseaseDiet, Gluten-FreeFemaleGlomerulonephritis, IGAGlutensGTP-Binding ProteinsHumansImmunoglobulin AIntestinal MucosaKidneyMaleMiddle AgedProtein Glutamine gamma Glutamyltransferase 2AutoantibodiesGlutensGTP-Binding ProteinsImmunoglobulin AProtein Glutamine gamma Glutamyltransferase 2Transglutaminasesceliac diseaseIgA nephropathytissue transglutaminase autoantibodytissue transglutaminase-targeted IgA deposits

Identifiers

PMID34064541
PMCPMC8150858
OpenAlexW3162583800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.